Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 12-2019 | |
| Sales | 1,198 | 8,478 | 0 |
| Gross Profit | 1,198 | 8,478 | N/A |
| Operating Expenses | 9,427 | 10,733 | 0 |
| Operating Income | -8,229 | -2,255 | N/A |
| Interest Expense | 6 | 5 | 0 |
| Other Income | 89 | 338 | 0 |
| Pre-tax Income | -8,146 | -1,922 | 0 |
| Income Tax | -213 | -50 | N/A |
| Net Income Continuous | -7,933 | -1,872 | N/A |
| Net Income | $-7,933 | $-1,872 | $N/A |
| EPS Basic Total Ops | -0.93 | -0.22 | N/A |
| EPS Basic Continuous Ops | -0.93 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.93 | -0.22 | N/A |
| EPS Diluted Continuous Ops | -0.93 | -0.22 | N/A |
| EBITDA(a) | $-8,003 | $-2,255 | $N/A |